Your browser doesn't support javascript.
loading
Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy.
Ishii, Takeo; Kumagae, Tomohiro; Wakui, Hiromichi; Urate, Shingo; Tanaka, Shohei; Abe, Eriko; Suzuki, Toru; Yamaji, Takahiro; Kinguchi, Sho; Kobayashi, Ryu; Haruhara, Kotaro; Nakamura, Takashi; Kobayashi, Shuzo; Tamura, Kouichi.
Afiliação
  • Ishii T; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
  • Kumagae T; Department of Medicine, Yokohama Daiichi Hospital, Kanagawa, Japan.
  • Wakui H; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
  • Urate S; Department of General Internal Medicine, Shonan Kamakura General Hospital, Kanagawa, Japan.
  • Tanaka S; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
  • Abe E; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
  • Suzuki T; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
  • Yamaji T; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
  • Kinguchi S; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
  • Kobayashi R; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
  • Haruhara K; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
  • Nakamura T; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
  • Kobayashi S; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
  • Tamura K; Medical Affairs Department, Sanwa Kagaku Kenkusho., Co., Ltd, Aichi, Japan.
FEBS Open Bio ; 11(2): 507-518, 2021 02.
Article em En | MEDLINE | ID: mdl-33448693
ABSTRACT
Xanthine oxidoreductase (XOR) is a critical enzyme in purine metabolism and uric acid production, and its levels are reported to increase during stress, thereby promoting organ damage. Herein, we investigated the activity of XOR in a mouse model of aristolochic acid I (AA)-induced nephropathy, a type of nephrotoxic chronic kidney disease (CKD). A persistent decrease in renal function was observed in mice up to 4 weeks after 4 weeks of AA (2.5 mg kg-1 ) administration. Renal histology revealed an increase in tubular interstitial fibrosis over time. Although AA administration did not change XOR activity in the plasma, heart, liver, or muscle, XOR activity was persistently increased in renal tissue. Our results suggest that the renal tissue-specific increase in XOR activity is involved in the progression of tubulo-interstitial disorders, specifically fibrosis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Xantina Desidrogenase / Insuficiência Renal Crônica / Túbulos Renais Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Xantina Desidrogenase / Insuficiência Renal Crônica / Túbulos Renais Idioma: En Ano de publicação: 2021 Tipo de documento: Article